Skip to main content
. 2026 Oct 4;18(19):3204. doi: 10.3390/cancers18193204
TIS Therapy-induced senescence
SASP Senescence-associated secretory phenotype
EMT Epithelial-to-mesenchymal transition
CSC Cancer stem cell
MET Mesenchymal-to-epithelial transition
SAS Senescent-associated secretome
ECM Extracellular matrix
ROS Reactive species oxygen
BTZ Bortezomib
TMZ Temozolomide
LUAD Lung adenocarcinoma
NSCLC Non-small-cell lung cancer
BLCA Bladder urothelial carcinoma
OXPHOS Oxidative phosphorylation
AI Artificial intelligence
ISRM Immunosenescence risk model
ISGS Immunosenescence gene set
CCS Cellular senescence-related signature
CTC Circulating tumour cell
EV Extracellular vesicle